Tag: healthcare
-
One step forward two steps back
Chasing the Yield – August 23, 2021 Episode 18 Value 4 Value podcastingListen to this podcast on PodFriend News https://www.chasingtheyield.com/2021/08/18/target-sales-up-8-9-year-over-year/ https://www.chasingtheyield.com/2021/08/18/main-street-capital-announces-38-5-million-in-investments/ https://www.chasingtheyield.com/2021/08/19/jjs-ceo-announces-hes-stepping-down/ Portfolio Update LowYield MediumYield HighYield Week -2.02% -2.37% -3.52% Month +0.93% -0.82% -5.30% 2021 +15.52% +12.67% -11.50% Inception +36.50% +8.00% -11.70% Dividends Received this Week Amount (OKE) $109.40 (ARTNA) $60.29 (KMI) $305.91 Dividends…
-
J&J’s CEO announces he’s stepping down
Johnson & Johnson Chief Executive Alex Gorsky is stepping aside, handing over the reins to the world’s largest health-products company to a longtime lieutenant after nearly a decade at the helm. Mr. Gorsky, who is 61 years old, will become J&J’s executive chairman effective Jan. 3. Joaquin Duato, who had led J&J’s pharmaceuticals business before…
-
Johnson & Johnson post higher profit
The New Brunswick, N.J.-based company logged sales of $23.31 billion—a 27% increase year over year—and adjusted earnings of $2.48 a share. Wall Street analysts had forecast adjusted earnings of $2.29 a share and revenue of $22.49 billion, according to FactSet’s survey. Wall Street Journal
-
Chasing The Yield Podcast – July 19, 2021
Markets are taking a dive, J&J has more problems, Microsoft blames Israeli group, OPEC reaches compromise, hotels eliminating housekeeping, and much more!
-
J&J gets slapped around a bit this week
Johnson & Johnson is not having a good week. First the FDA added a warning to the label for the company’s COVID-19 vaccine. The warning states that there may be a risk of contracting Guillain-Barre syndrome. The US Food and Drug Administration updated the label on Johnson & Johnson’s coronavirus vaccine Monday to warn of the possible…